CPV – Page 36 – Pharma.Tips

End-point detection failure post-technology transfer – inspection-ready justification

Addressing End-point Detection Failures After Technology Transfer: A Structured Approach End-point detection failure following a technology transfer is a common issue encountered in pharmaceutical manufacturing, especially during the granulation process.…

FBD drying inefficiency during validation – process robustness improvement plan

Enhancing FBD Drying Efficiency During Validation: A Comprehensive Problem-Solution Approach Fluidized Bed Dryers (FBD) are critical components in the pharmaceutical manufacturing process, particularly during granulation. However, inefficiencies in the drying…

Non-uniform granule size during scale-up – process robustness improvement plan

Improving Process Robustness Against Non-uniform Granule Size During Scale-up In pharmaceutical manufacturing, achieving uniformity in granule size during the scale-up phase is critical for product quality and performance. Non-uniform granule…

Binder distribution variability during CPV trending – GMP-compliant optimization approach

Optimizing Binder Distribution Variability in Continuous Process Verification Binder distribution variability can significantly impair the quality and efficiency of the granulation process, leading to deviations in batch yields and potential…

RMG torque instability post-technology transfer – process robustness improvement plan

Addressing RMG Torque Instability After Technology Transfer for Enhanced Process Robustness In the pharmaceutical manufacturing landscape, achieving consistent and reliable process performance is critical. A common issue that arises during…

Over-wetting risk during CPV trending – process robustness improvement plan

Addressing the Over-wetting Risk in Continuous Process Verification Trending In the realm of pharmaceutical manufacturing, ensuring process consistency and product quality is paramount. One common concern is the risk of…

Over-wetting risk during wet granulation – inspection-ready justification

Understanding and Mitigating Over-wetting Risks in Wet Granulation for Pharma Manufacturing In pharmaceutical manufacturing, the granulation process plays a pivotal role in achieving the desired quality and performance of solid…

Granule friability issue during CPV trending – GMP-compliant optimization approach

Addressing Granule Friability Challenges During CPV Trending with a GMP-Compliant Strategy Granule friability is a critical parameter in pharmaceutical manufacturing that directly impacts quality and yield. It is particularly relevant…

Binder distribution variability during wet granulation – GMP-compliant optimization approach

Addressing Variability in Binder Distribution During Wet Granulation for Optimized GMP Compliance In the pharmaceutical manufacturing environment, ensuring the uniformity of binder distribution during the wet granulation process is critical…

Granule friability issue during scale-up – GMP-compliant optimization approach

Addressing Granule Friability Challenges in Scale-Up: A GMP-Centric Approach Granule friability issues during the scale-up phase can hinder production efficiency and impact product quality, leading to significant operational challenges. As…

End-point detection failure during wet granulation – GMP-compliant optimization approach

Addressing End-Point Detection Failure in Wet Granulation for Improved GMP Compliance End-point detection failure during wet granulation poses significant challenges in pharmaceutical manufacturing. This issue can lead to an inconsistent…

Non-uniform granule size during validation – GMP-compliant optimization approach

Optimizing Granulation: Addressing Non-Uniform Granule Size During Validation In the pharmaceutical manufacturing landscape, ensuring uniform granule size is a critical factor affecting both product efficacy and regulatory compliance. Non-uniform granule…